Deal typeTransaction Services
IndustryHealthcare & Life Sciences
Client nameFagron BV
BDO are delighted to have supported Fagron with financial and tax due diligence services, on their acquisition of London Specialist Pharmacy.
London Specialist Pharmacy is the UK's number 1 compounding pharmacy, producing custom-made medications for hormone-related conditions to help doctors offer personalised formulations for more effective treatment, and give patients access to better medication across a wider range of treatment options.
The acquisition by Fagron, an international provider of Pharmaceutical Compounding & Sterile Outsourcing Services, will open new avenues for growth and innovation serving patients while personalizing medicine for the Group.
The BDO project team included:
Graeme Hurst, Lewis Winston, Stephen Moss, James Ferguson (Financial due diligence)
Sam Boundy, Will Searle, Amy Hoare (Tax)
Lawrence McGinley (SPA)
London Specialist Pharmacy is the UK's number 1 compounding pharmacy, producing custom-made medications for hormone-related conditions to help doctors offer personalised formulations for more effective treatment, and give patients access to better medication across a wider range of treatment options.
The acquisition by Fagron, an international provider of Pharmaceutical Compounding & Sterile Outsourcing Services, will open new avenues for growth and innovation serving patients while personalizing medicine for the Group.
The BDO project team included:
Graeme Hurst, Lewis Winston, Stephen Moss, James Ferguson (Financial due diligence)
Sam Boundy, Will Searle, Amy Hoare (Tax)
Lawrence McGinley (SPA)